Novavax (NASDAQ: NVAX) net income
Novavax reported a net profit of $440.3m for fiscal 2025; in fiscal 2024 it reported a net loss of $187.5m. Its net margin was 39.2%. Earnings per share were $2.72.
Fiscal 2025 is the highest of the 10 fiscal years on record for Novavax. It reported a loss in 9 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $440.3m | — | 39.2% | $2.72 |
| 2024 | −$187.5m | — | −27.5% | −$1.23 |
| 2023 | −$545.1m | — | −55.4% | −$5.41 |
| 2022 | −$657.9m | — | −33.2% | −$8.42 |
| 2021 | −$1,744m | — | −152.1% | −$23.44 |
| 2020 | −$418.3m | — | −87.9% | −$7.27 |
| 2019 | −$132.7m | — | −711.0% | −$5.51 |
| 2018 | −$184.7m | — | −538.8% | — |
| 2017 | −$183.8m | — | −589.5% | — |
| 2016 | −$280.0m | — | −1,823.5% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Novavax net income compared with its sector
By net income for its latest fiscal year, Novavax ranks 64th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Novavax, 39.2%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 62nd | Medpace | $451.1m | 17.8% |
| 63rd | TG Therapeutics | $447.2m | 72.6% |
| 64th | Novavax | $440.3m | 39.2% |
| 65th | Align Technology | $410.4m | 10.2% |
| 66th | Henry Schein | $398.0m | 3.0% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Novavax
- How much did Novavax earn in fiscal 2025?
- Novavax reported a net profit of $440.3m for fiscal 2025. In fiscal 2024 it reported a net loss of $187.5m.
- What are the earnings per share of Novavax?
- They were $2.72 in fiscal 2025, compared with −$1.23 in fiscal 2024.
- What is the net margin of Novavax?
- In fiscal 2025 its net profit was 39.2% of its revenue.
- What was the most profitable year for Novavax?
- Of its last 10 fiscal years, fiscal 2025, with $440.3m.
- Where does Novavax rank in its sector by net income?
- It ranks 64th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Novavax come from?
- From the annual report (Form 10-K) that Novavax files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Novavax files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Novavax: the Novavax page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.